FENNEC PHARMACEUTICALS INC. - Common Shares (FENC)

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class: Equity / Common Shares
Shares outstanding: 27,691,200
Number of holders: 16
Total 13F shares, excl. options: 6,949,133
Shares change: +1,801,188
Total reported value, excl. options: $69,588,032
Value change: +$18,006,732
Number of buys: 13
Price: $10

Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q4 2017

16 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q4 2017.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 6,949,133 shares of 27,691,200 outstanding shares and own 25.1% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (3,997,214 shares), 683 Capital Management, LLC (867,185 shares), Opaleye Management Inc. (846,900 shares), EVENTIDE ASSET MANAGEMENT, LLC (741,175 shares), ACUTA CAPITAL PARTNERS, LLC (250,000 shares), PUTNAM INVESTMENTS LLC (117,645 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (59,044 shares), UNITED SERVICES AUTOMOBILE ASSOCIATION (52,848 shares), Cardinal Capital Management (12,037 shares), and Hartford Financial Management Inc. (2,150 shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.